Dr. Daniel A. Vincent Jr., FACS, MD

Dr. Vincent practices at ENT and Allergy Associates of Florida in Boca Raton, Florida.

Dr. Vincent's NPI, 1740282623, was assigned on August 11, 2005. Dr. Vincent graduated from USF Health Morsani College of Medicine in 1990. Dr. Vincent holds Florida license ME75546.

Dr. Vincent's primary practice is ENT and Allergy Associates of Florida, at 900 NW 13th St, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 338-3267.

Dr. Vincent's primary practice is ENT and Allergy Associates of Florida in Boca Raton, Florida. Dr. Vincent is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is ENT & Allergy Associates of Florida. Dmand AI also links Dr. Vincent to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vincent practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Vincent's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Vincent is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Vincent's licenses on file in 3 states: Florida, Minnesota and South Carolina.

Dmand AI lists chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Vincent treats.

CMS data shows 765 Medicare services from Dr. Vincent across 12 procedure codes in 2024, for 261 Medicare patients. Medicare paid $39,706 for them.

CMS counts 261 Medicare patients who saw Dr. Vincent in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vincent's median patient age at 69, with 53% women.

In 2024, Dr. Vincent wrote 370 Medicare Part D claims for 125 patients. 98% of them were for generic drugs. CMS names the drug for 266 of them, across 8 drugs with 11 or more claims each, at $3,125 in total drug cost. In 2023, CMS named 531 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Vincent for performance year 2024, reported individually. Dr. Vincent accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Vincent, published from 2007 to 2016. 2014 was the busiest year, with 2. The most frequent topics are Genetic Predisposition to Disease, Polymorphism, Single Nucleotide and Breast Neoplasms. Dr. Vincent has published most often in Breast Cancer Res. Dr. Vincent's most frequent co-authors are Antonis Antoniou, MD, Gerald L. Andriole, MD and Susan M. Domchek, MD.

CMS Open Payments shows 56 general payments to Dr. Vincent from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Intersect ENT, Inc. paid the most, $249.

Dmand AI lists 5 awards for Dr. Vincent, most recently CMS Stage 1 EHR in 2013.

Dr. Vincent graduated from USF Health Morsani College of Medicine in 1990. Dr. Vincent is a member of NHS and ACS.

Dr. Vincent is in network with 14 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.